KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 118 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $2,000 | 0.0% | 125 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $2,000 | -33.3% | 125 | -50.0% | 0.01% | +25.0% |
| Q1 2017 | $3,000 | -62.5% | 250 | 0.0% | 0.00% | -60.0% |
| Q1 2015 | $8,000 | +60.0% | 250 | +100.0% | 0.01% | +66.7% |
| Q4 2014 | $5,000 | – | 125 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |